Bone Metastasis - Pipeline Review, H2 2012 New Report
Bone Metastasis - Pipeline Review, H2 2012, provides an overview of the Bone Metastasis therapeutic pipeline. This report provides information on the therapeutic development for Bone Metastasis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bone Metastasis. 'Bone Metastasis - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured...
View full press release